1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Refractory Cutaneous T-cell Lymphoma: new trials by email Literature Review of Refractory Cutaneous T-cell Lymphoma trials Research Report on Refractory Cutaneous T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) Bexarotene - Refractory Cutaneous T-cell Lymphoma | Phase 4 | Completed | Bausch Health Americas, Inc. | 59 | 2010-01-06 | 2019-11-12 |
Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Bexarotene (1)
Bausch Health Americas, Inc. (1)
United States (1)
Mandeep Kaur, MD (1)